< Back to latest news & events

Awards

HGF ranked Gold in the FT special report – Europe’s Leading Patent Law Firms 2022

June 2022

HGF has been ranked in the ‘Gold’ and ‘Silver’ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on the 16th June 2022.

More than 10,000 patent attorneys working in patent law firms or in the patent departments of companies, as well as clients, were directly invited to take part in the survey. Survey participants could recommend firms both in general and by specialities, categorised into six sectors. The sample was collected via research conducted by Statista on relevant company websites, in publications and from the EPI (the Institute of Professional Representatives Before the European Patent Office), the professional body representing European patent attorneys.

The firm is one of the leading firms of IP specialists in Europe, with 22 offices across the UK, Germany, The Netherlands, Switzerland, Austria, France and Ireland, and is internationally recognised by its peers across these core areas of technology.

HGF has been ranked in Gold “very frequently recommended” for:

  • Biotechnology & Food
  • Chemistry & Pharmaceuticals
  • Mechanical Engineering

Silver for “ frequently recommended” for:

  • Electrical Engineering
  • IT & Software
  • Materials & Nanotechnology

Dr Andrew Wells, Head of the Chemistry team commented,  “I’m delighted that our excellent reputation in the chemistry field has been recognised.  This is an excellent achievement for the HGF Chemistry team and for HGF as a whole. We have a large team of chemical patent attorneys located throughout Europe and we pride ourselves on providing commercially relevant and strategic IP advice to our clients.  We cover the whole chemistry landscape and have seen significant growth in the key areas of pharmaceuticals, formulation science, materials science, agrochemicals, process chemistry, fuel cells and electrochemistry. We also have a significant European oppositions practice that continues to go from strength to strength”.

Lucy Johnson, Head of the Engineering team commented, “We are delighted. Receiving a gold ranking recognition from our clients and peers is a reflection of the exceptional quality of the HGF Engineering team across Europe. The team has a wealth of technical and in-house expertise enabling us to provide strategic and relevant IP advice across the Engineering landscape.  Our work and reputation in the energy, automotive and healthcare sectors, in particular, is key to continuing to grow and develop our client partnerships”.

Kate Taylor, Head of the Life Sciences team commented, “Receiving this ranking is testament to the exceptional technical and legal knowledge of the HGF life sciences team in what is a continuingly evolving technology landscape. We have a depth of expertise across the sector, and of particular note is the work we have been undertaking in the area of CRISPR, Microbiome and biologic therapeutics”.

As one of Europe’s leading firms  firm we are committed to building strong client relationships and delivering outstanding service from our offices in Germany, The Netherlands, Switzerland, Austria, France, Ireland and the UK. We continue to deepen our understanding of the client experience and provide tailor made solutions for our clients in Europe and around the world. We are delighted to have been ranked in Gold and Silver, and believe it is our integrated approach providing multidisciplinary teams of patent attorneys, trade mark attorneys and IP solicitors; each guided by the great value we place on People, Teamwork, Excellence and Progressive.

For the full report see here

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article